FdaApplication
ANDA 206074
Identifiers
- fda_app_no: ANDA206074
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA USA LLC |
| application_type | ANDA |
| approval_date | 2017-11-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOPOTECAN HYDROCHLORIDE | TOPOTECAN HYDROCHLORIDE | EQ 4MG BASE/4ML (EQ 1MG BASE/ML) | SOLUTION;INTRAVENOUS |
1 product